Jump to content

Helen S. Mayberg: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
KolbertBot (talk | contribs)
m Bot: HTTP→HTTPS (v473)
Rescuing 1 sources and tagging 0 as dead. #IABot (v1.6)
Line 4: Line 4:
==Service and Awards==
==Service and Awards==


Mayberg is active in a wide variety of scientific organizations including the Society for Neuroscience, the Society of Biological Psychiatry, the American Neurological Association, the American College of Neuropsychopharmacology, and the Organization for Human Brain Mapping. She is a current member of the Dana Alliance and the [[Brain & Behavior Research Foundation]] Scientific Council, and serves on the editorial boards of the journals Neuroimage, Human Brain Mapping, Brain Stimulation, Neuroinformatics, Brain Imaging, and Behavior and Brain Structure and Function. She was elected to the Institute of Medicine of the National Academies in 2008. Dr. Mayberg is also a member of the Governing Board of the [[International Neuroethics Society]].<ref name=INS>{{cite web|title=Governance|url=http://www.neuroethicssociety.org/governance|website=International Neuroethics Society|accessdate=28 September 2014}}</ref>
Mayberg is active in a wide variety of scientific organizations including the Society for Neuroscience, the Society of Biological Psychiatry, the American Neurological Association, the American College of Neuropsychopharmacology, and the Organization for Human Brain Mapping. She is a current member of the Dana Alliance and the [[Brain & Behavior Research Foundation]] Scientific Council, and serves on the editorial boards of the journals Neuroimage, Human Brain Mapping, Brain Stimulation, Neuroinformatics, Brain Imaging, and Behavior and Brain Structure and Function. She was elected to the Institute of Medicine of the National Academies in 2008. Dr. Mayberg is also a member of the Governing Board of the [[International Neuroethics Society]].<ref name=INS>{{cite web|title=Governance|url=http://www.neuroethicssociety.org/governance|website=International Neuroethics Society|accessdate=28 September 2014|deadurl=yes|archiveurl=https://web.archive.org/web/20141006113504/http://www.neuroethicssociety.org/governance|archivedate=6 October 2014|df=}}</ref>


==Recent Publications==
==Recent Publications==

Revision as of 13:36, 1 November 2017

Helen S. Mayberg was born in 1956 in California. She is an American neurologist. Mayberg is known in particular for her work delineating abnormal brain function in patients with major depression using functional neuroimaging. This work led to the first pilot study of deep brain stimulation (DBS), a reversible method of selective modulation of a specific brain circuit, for patients with treatment-resistant depression.

Service and Awards

Mayberg is active in a wide variety of scientific organizations including the Society for Neuroscience, the Society of Biological Psychiatry, the American Neurological Association, the American College of Neuropsychopharmacology, and the Organization for Human Brain Mapping. She is a current member of the Dana Alliance and the Brain & Behavior Research Foundation Scientific Council, and serves on the editorial boards of the journals Neuroimage, Human Brain Mapping, Brain Stimulation, Neuroinformatics, Brain Imaging, and Behavior and Brain Structure and Function. She was elected to the Institute of Medicine of the National Academies in 2008. Dr. Mayberg is also a member of the Governing Board of the International Neuroethics Society.[1]

Recent Publications

  • Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic [2]
  • Differences in Brain Glucose Metabolism Between Responders to CBT and Venlafaxine in a 16-Week Randomized Controlled Trial [3]
  • Defining the Neural Circuitry of Depression: Toward a New Nosology With Therapeutic Implications [4]

References

  1. ^ "Governance". International Neuroethics Society. Archived from the original on 6 October 2014. Retrieved 28 September 2014. {{cite web}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  2. ^ Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic : Abstract : Nature Neuroscience
  3. ^ Differences in Brain Glucose Metabolism Between Responders to CBT and Venlafaxine in a 16-Week Randomized Controlled Trial - Kennedy et al. 164 (5): 778 - Am J Psychiatry
  4. ^ Elsevier Article Locator